MeSH term
Frequency | Condition_Probility | Adult | 6 | 0.0 |
Aged | 2 | 0.0 |
Child | 5 | 0.0 |
DNA Mutational Analysis | 8 | 0.0 |
DNA Primers/chemistry | 3 | 0.0 |
DNA-Binding Proteins/*genetics | 7 | 0.0 |
Dark Adaptation | 2 | 5.0 |
Electroretinography | 3 | 1.0 |
Eye Proteins/*genetics | 8 | 4.0 |
Female | 11 | 0.0 |
Humans | 29 | 0.0 |
Leucine Zippers/genetics | 5 | 10.0 |
Male | 9 | 0.0 |
*Mutation, Missense | 2 | 0.0 |
Pedigree | 6 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 24 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 21 | 0.0 |
Rhodopsin/genetics | 4 | 21.0 |
Visual Acuity | 3 | 1.0 |
Animals | 16 | 0.0 |
Base Sequence | 8 | 0.0 |
Immunohistochemistry | 4 | 0.0 |
Leucine Zippers | 3 | 1.0 |
Mice | 11 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Cattle | 3 | 0.0 |
Molecular Sequence Data | 11 | 0.0 |
Mutation/*genetics | 3 | 0.0 |
Cell Differentiation | 4 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Immunoblotting | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Time Factors | 3 | 0.0 |
Transfection | 5 | 0.0 |
Promoter Regions (Genetics) | 5 | 0.0 |
Rods (Retina)/*enzymology | 2 | 25.0 |
Trans-Activation (Genetics) | 4 | 0.0 |
Transcription Factors/*physiology | 2 | 0.0 |
*Transcription, Genetic | 3 | 0.0 |
Genes, Dominant | 3 | 0.0 |
Middle Aged | 3 | 0.0 |
Mutation | 4 | 0.0 |
Phenotype | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Rats | 3 | 0.0 |
Amino Acid Sequence | 7 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
In Situ Hybridization | 3 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Patch Tests | 2 | 6.0 |
Prognosis | 2 | 0.0 |
Risk Assessment | 2 | 0.0 |
Eye Proteins/*genetics/metabolism | 2 | 7.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Gene Expression Regulation, Developmental/*physiology | 2 | 1.0 |
Photoreceptors, Vertebrate/*metabolism | 2 | 12.0 |
Retina/*embryology | 2 | 22.0 |
Chromosome Mapping | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
*Acute-Phase Proteins | 2 | 1.0 |
*Oncogene Proteins | 2 | 3.0 |
Retinal Degeneration/*genetics | 2 | 5.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Transcription Factors/*genetics | 2 | 0.0 |
DNA-Binding Proteins/*physiology | 2 | 0.0 |
Eye Proteins/*physiology | 2 | 22.0 |
*Promoter Regions (Genetics) | 3 | 0.0 |
Cell Line | 2 | 0.0 |
DNA/metabolism | 2 | 0.0 |
Glutathione Transferase/metabolism | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Leucine Zippers/*genetics | 2 | 9.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Retina/*metabolism | 2 | 3.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Syndrome | 2 | 0.0 |
*Mutation | 2 | 0.0 |
